AI-generated content for informational purposes only. Not financial advice. Always do your own research.

Over

MetLife, Inc. (NYSE: MET) is een wereldleider in verzekeringen, annuïteiten en personeelsbeloningsprogramma's, en bedient ongeveer 100 miljoen klanten in meer dan 40 landen. Het bedrijf is actief in segmenten waaronder de VS, Azië, Latijns-Amerika en Europa, het Midden-Oosten en Afrika, en biedt groeps- en individuele levensverzekeringen, tandheelkundige, arbeidsongeschiktheids- en pensioen- en spaarproducten aan. MetLife onderscheidt zich als verzekeringaandeel vanwege zijn internationale diversificatie en dominante positie in de Amerikaanse markt voor groepsuitkeringen.

Verzekeringsaandelen

MetLife is een wereldwijd gediversificeerd verzekeringsbedrijf met een leidinggevende positie in zowel levensverzekering als werknemersbaten. De uitgebreide internationale aanwezigheid en schaal in groepsbaten onderscheiden het van inlandse verzekeraars gericht, bieden beleggers brede blootstelling aan wereldwijde verzekeringsvraag.

Key Financials MET

Prijs $77.31
Wijziging (1D) -0.06%
Wijziging (30D) -2.06%
Wijziging (60D) +2.36%
Wijziging (90D) -6.12%
Wijziging (180D) -0.87%
Wijziging (1Y) -6.55%
Wijziging (5Y) +42.06%
P/E-verhouding 8.75
EPS (TTM) $8.84
52-weekse bandbreedte $65.21 — $87.39
50-daags MA $78.86
Volume 3.11M

Data updated Feb 15 · Source: Twelve Data

4.2
2 reviews
Valuation
4.4
Fundamentals
4.3
Management Quality
4.2
Performance
3.8
Risk Profile
3.8
Claude Opus 4.6
AI Review
4.1/5

MetLife is one of the world's largest insurance and employee benefits providers, with a diversified global footprint spanning the U.S., Asia, Latin America, and EMEA. The stock trades at a compelling P/E of 8.75 with strong EPS of $8.84, reflecting the value-oriented nature typical of large-cap insurers. The 42% five-year return demonstrates solid long-term wealth creation, though the stock has pulled back roughly 6.5% over the past year and sits below its 50-day moving average, suggesting near-term momentum headwinds.

Bull case: MetLife's diversified revenue streams, disciplined capital return program (consistent buybacks and dividends), and exposure to higher interest rates supporting investment income make it attractive at current valuations. The Group Benefits segment provides stable, recurring revenue.

Bear case: Sensitivity to equity market volatility through variable annuity guarantees, macroeconomic uncertainty impacting international operations, and potential for elevated catastrophe losses pose risks. Competition from insurtechs and evolving regulatory landscapes add pressure.

Overall, MetLife offers a solid value proposition for income-oriented investors seeking insurance sector exposure at a reasonable price.

Valuation
4.4
Fundamentals
4.3
Management Quality
4.2
Performance
3.8
Risk Profile
3.8
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.2/5

MetLife stands as a dominant force in the global life insurance and employee benefits sector, offering a compelling value proposition with a P/E ratio of approximately 10.9x. The company benefits significantly from its diversified geographic footprint across the U.S., Asia, and Latin America, which helps mitigate regional risks. Financially, MetLife is well-positioned to capitalize on the current interest rate environment, which generally boosts net investment income for insurers. With a robust EPS of $7.17, the company demonstrates strong earnings power and capital generation capabilities.

However, risks remain. Investors should closely monitor the company's investment portfolio exposure to commercial real estate, a sector facing ongoing volatility. Additionally, with the stock trading slightly below its 50-day moving average and off its 52-week high, there is some short-term technical consolidation. Overall, MET represents a solid, defensive choice for value-oriented investors seeking stability and exposure to the financial sector.

Feb 11, 2026
MetLife Screenshot

Added: Feb 10, 2026

metlife.com

Latest from Otrai